Layn(SZ:002166) Zheng Quan Shi Bao Wang·2025-12-23 13:41Core Viewpoint - The company, Rhein Biotech, plans to acquire an 80% stake in Beijing Jinkangpu Food Technology Co., Ltd., a leading provider of nutritional fortifiers for infant formula, thereby expanding its industry chain into the nutritional fortifier compounding sector [1] Group 1: Acquisition Details - Rhein Biotech intends to issue shares to Defu Jinkangpu and Xiamen Defu Jinkangpu to purchase their combined 80% stake in Beijing Jinkangpu [1] - The transaction is still pending completion of auditing and evaluation work [1] Group 2: Strategic Implications - The acquisition will create a closed-loop industry chain from upstream raw materials to downstream formulation solutions in the nutritional fortifier sector [1] Group 3: Shareholder Changes - On December 22, Guangzhou Defu Nutrition signed an agreement with the company's original controlling shareholder, Qin Benjun, to transfer 8.09% of shares and relinquish voting rights for 25.5% of shares, retaining voting rights for 3% [1] - Following the share transfer and board restructuring, Guangzhou Defu Nutrition will become the controlling shareholder, with Hou Ming and Li Zhenfu as co-controlling persons [1] - Guangzhou Defu Nutrition, Defu Jinkangpu, and Xiamen Defu Jinkangpu are related entities under common control [1] Group 4: Stock Resumption - The company's stock will resume trading on December 24 [1]